Please contact your state congressional representatives to demand
that they pass an emergency mandate requiring that drug/biologic manufacturers list
contraindication warnings for these products based on the “source of the excipients.”
Thank you very much for your contribution to this effort.
Diane H., Corn Allergy Advocate
Corn Allergy Advocacy/Resources
Twitter: @CornAllergy911
------------------------------------------------------
My June 8, 2020, Appeal to My State Congressional
Representatives Requesting Contraindication Warnings for Drug/Biologic Products
Based on the “Source of Excipients”
“What allergen restricts access to basic human requirements:
fresh foods, water, drugs, and clothing? CORN!"
This is the title of the next article I am writing, which will
include studies, statistics, and devastating personal testimonies confirming
the daily struggle for survival with an allergy to corn [not recognized as an
official allergen].
However, I want to address the lack of available drugs for
corn-allergic patients immediately; since corn-derived excipients are not only
used as common fillers in the majority of prescription/OTC drug/biologic
products, but these drugs contain NO CONTRAINDICATION WARNING FOR
ADMINISTRATION TO CORN-ALLERGIC PATIENTS BASED ON THE SOURCE OF THESE
EXCIPIENTS.
In our corn allergy support groups of over 12K members [note that
this is more than double the members of sesame seed allergy support groups], we
read testimonies daily of physicians prescribing drugs to their corn-allergic
patients which contain inactive ingredients derived from corn; thereby,
resulting in unnecessary allergic reactions (including anaphylaxis) to their
patients. This is due to the fact that drugs containing corn-derived
excipients do not currently contain a contraindication warning for
administration to corn-allergic patients based on the source of the
excipients.* Since physicians and pharmacists are not educated to understand
the dangers of NMIs (non-medicinal ingredients) in drug/biologic products; and
particularly since these drug/biologic products lack the critical
contraindication warnings, these unfortunate incidents occur nearly every day.
Reprinted with permission (pharmacist who is member of a corn
allergy support group):
"I’m a pharmacist who works in community practice. Earned
my doctorate in 2007. We don’t learn hardly anything about the sources of
inactive ingredients in school. I would never have known that so many meds have
corn and corn derivatives in them unless my son had been diagnosed with FPIES
in 2015. I would venture to say only a handful of other pharmacists nationwide
are aware of this particular issue." - Pharmacist
I have just forwarded an appeal to the FDA to pass an emergency
mandate requiring that drug/biologic product manufacturers be required to list
contraindication warnings based on the 'SOURCE OF EXCIPIENTS' in these products
for the safety of all patients diagnosed with
allergies.
I also forwarded this appeal to the majority of pharmaceutical
companies with a hope that they will immediately adopt this practice prior to a
mandate being issued.
We would appreciate your assistance on behalf of all citizens
suffering with allergies.
Sincerely,
Diane H., Corn Allergy Advocate
*There are only a handful of drugs containing this warning;
e.g., IV drugs w/dextrose (corn sugar derived from cornstarch per Code of
Federal Regulation 21CFR184.1857), and even these contraindication warnings are
inconsistent. Due to the fact that most physicians continue to miss
this critical contraindication warning on IV fluids w/dextrose, it took me
three years to forward the package insert to our nation's hospitals, colleges
of medicine, and colleges of pharmacy."
References:
My June 5, 2020, Email to the FDA Re: Emergency Mandate
Requiring Contraindication Warnings be Listed for Drug/Biologic Products Based
on the "Source of Excipients"
PHARMACISTS CONFIRM THE STUDY OF NMIs (NON-MEDICINAL
INGREDIENTS) IN DRUGS IS NOT PART OF CURRICULUM
https://cornallergyadvocacyresources.blogspot.com/2020/06/pharmacists-confirm-study-of-nmis-non.html
PETITION: DRUG PRODUCTS W/DEXTROSE MUST BE UNIFORMLY
CONTRAINDICATED FOR CORN-ALLERGIC PATIENTS
United States Hospitals/Health Systems Contacted Re: Protocol
for Treating Corn-Allergic Patients
https://cornallergyadvocacyresources.blogspot.com/2017/07/united-states-hospitalshealth-systems.html
Colleges of Medicine Contacted Re: Protocol for Treating
Corn-Allergic Patients
Colleges of Pharmacy Contacted Re: Protocol for Treating
Corn-Allergic Patients
Pharmaceutical Companies Contacted Re: Protocol for Treating
Corn-Allergic Patients
Corn Allergy for Newbies
Corn Allergy: A Potentially Life-Threatening Diagnosis
FDA AND USDA CONFIRM THAT CORN-DERIVED ANTIMICROBIAL CHEMICALS
APPLIED TO FRESH FOOD PRODUCTS ARE EXEMPT FROM PUBLIC DISCLOSURE
A mother's desperate struggle to find safe water for her
corn-allergic infant son.
May, 2020, Month-End Corn Allergy Statistics: 935.2% Increase in
83 Months
(Corn is ubiquitous and corn allergen warnings are voluntary.)
Source:
Senators of the 116th Congress
https://www.senate.gov/general/contact_information/senators_cfm.cfm
United States House of Representatives 116th Congress
United States House of Representatives 116th Congress
No comments:
Post a Comment